Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance-Reference-Cited by-同舟云学术

Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance

Published:2021-05 Issue: Volume:235 Page:104-112
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Nicholls StephenJ,Lincoff A Michael,Bays Harold E,Cho Leslie,Grobbee Diederick E,Kastelein John JP,Libby Peter,Moriarty Patrick M,Plutzky Jorge,Ray Kausik K,Thompson Paul D.,Sasiela William,Mason Denise,McCluskey Jaclyn,Davey Deborah,Wolski Kathy,Nissen Steven E

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Cholesterol Treatment Trialists;Lancet,2010

2. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol;Grundy;Circulation,2018

3. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis;Jones;J Am Heart Assoc,2012

4. Association of a combined measure of adherence and treatment intensity with cardiovascular outcomes in patients with atherosclerosis or other cardiovascular risk factors treated with statins and/or ezetimibe;Khunti;JAMA Netw Open,2018

5. The forgotten majority: unfinished business in cardiovascular risk reduction;Libby;J Am Coll Cardiol,2005

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of cardiovascular outcomes with bempedoic acid in high-risk statin intolerant patients: a systematic review and meta analysis;Future Cardiology;2024-08-14

2. Animal-based evidence supports the influence of biogenic silver and gold nanomaterials on the serum lipid profile: A novel approach in antihyperlipidemia management;Results in Surfaces and Interfaces;2024-08

3. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024;BMC Nephrology;2024-07-06

4. Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs;Journal of the American College of Cardiology;2024-07

5. A Systematic Review and Meta-Analysis on the Role of Bempedoic Acid in Cardiovascular Outcomes for Patients With Statin Intolerance;Cureus;2024-06-03